Alfred Sze‐Lok Cheng

机构：Chinese University of Hong Kong · ORCID：0000-0001-5503-5882

发表论文 37 篇 · 总被引 502 次 · h-index 8

代表论文

• Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition (2021 · Advanced Science · 被引 193)
• Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma (2023 · Gut · 被引 115)
• MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target (2022 · Theranostics · 被引 45)
• Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma (2024 · Gut · 被引 42)
• Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8/CXCR2 signaling (2025 · Molecular Therapy · 被引 37)
• Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients (2022 · Gut · 被引 34)